Bausch Health Companies

Synergetics USA, Inc. is a medical device company headquartered in O'Fallon, Missouri, specializing in precision surgical devices and equipment primarily for the ophthalmology and neurosurgery markets. The company offers around 1,000 products, including disposable and reusable devices, surgical equipment, and procedural kits that utilize various energy modalities, such as laser, ultrasonic, and radio frequency energy. Notable products include the VersaVIT 2.0 vitrectomy system, procedural packs under the VersaPACK and Core Essentials brands, fiberoptic endoilluminators, and endolaser probes. Additionally, Synergetics USA provides illumination equipment and laser systems tailored for the U.S. market. Its products are sold directly as well as through distributors and independent sales representatives, targeting end-users in hospitals, ambulatory surgery centers, and surgical offices. The company has been in operation since 1991 and functions as a subsidiary of Valeant Pharmaceuticals International.

Sprout Pharmaceuticals, Inc. is a company focused on developing treatments for female sexual health, specifically addressing female sexual dysfunction. Founded in 2011 and headquartered in Raleigh, North Carolina, the company offers Addyi, a non-hormonal pill designed for the treatment of acquired and generalized hypoactive sexual desire disorder in premenopausal women in the United States. Sprout Pharmaceuticals aims to pioneer advancements in women's sexual health, making significant contributions to the field since its inception.

Amoun Pharmaceutical Company S.A.E. is engaged in the development, manufacturing, marketing, and distribution of a diverse range of human pharmaceutical and animal health products, primarily in Egypt. Established in 1998 and headquartered in Cairo, the company exports its products to around 28 countries across the Middle East, Africa, Asia, and Europe. Amoun's extensive product portfolio addresses various therapeutic needs, including treatments for high-prevalence diseases and conditions of national interest. The company maintains a strong pipeline, with over 30 new products at various stages of registration, aimed at meeting unmet healthcare demands. By focusing on quality healthcare solutions, Amoun Pharmaceutical is positioned to contribute significantly to the health sector while driving growth and enhancing value for its stakeholders.

Salix Pharmaceuticals is a specialty pharmaceutical company committed to the prevention and treatment of gastrointestinal (GI) disorders. For more than 20 years, they have licensed, developed, and marketed innovative products to treat GI problems. It's their mission to give healthcare providers and patients the most effective solutions in gastroenterology.

Dendreon Pharmaceuticals, Inc., a biotechnology company, discovers, develops, manufactures, and sells novel therapeutics products. It offers PROVENGE (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer. The company was incorporated in 2015 and is based in Seattle, Washington. It has manufacturing facilities in Seal Beach, California; and Union City, Georgia. As of June 29, 2017, Dendreon Pharmaceuticals, Inc. operates as a subsidiary of Sanpower Group Co., Ltd.

Valeo Medical, Inc., a life sciences company, develops a non-invasive diagnostic blood test for endometriosis. The company was founded in 2003 and is based in Burlington, Massachusetts. Valeo raised money as part of the Discovery Life Sciences fund which was partly funded by the Nashville Capital Network.

PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding rapidly through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities.

Solta Medical, Inc. specializes in designing, developing, manufacturing, and marketing energy-based medical devices focused on aesthetic applications. The company offers a range of products, including the Thermage NXT system for non-invasive skin tightening and contouring, and the Fraxel series of systems that treat various skin conditions such as fine lines, pigmentation, acne scars, and deeper wrinkles. Their devices incorporate advanced technology with handpieces, user-friendly consoles, and disposable treatment tips. Solta Medical serves a diverse clientele, including dermatologists, plastic surgeons, and general practitioners, and distributes its products through a direct sales force and a network of international distributors. Founded in 1995 and headquartered in Hayward, California, the company was previously known as Thermage, Inc. before rebranding in 2009.

Bausch + Lomb is a prominent eye health company with a rich history dating back to 1853, when it began as a small optical shop in Rochester, New York. Now a multi-billion dollar corporation, Bausch + Lomb employs approximately 13,000 individuals and offers a comprehensive portfolio of eye health products available in over 100 countries. The company operates in three key segments: vision care, surgical, and ophthalmic pharmaceuticals. In the vision care segment, it holds a 10% share of the contact lens market, and its ocular health products include well-known brands like Biotrue and Lumify. The surgical segment provides a range of intraocular lenses and equipment for cataract and vitreoretinal surgeries. Finally, the ophthalmic pharmaceuticals segment features a diverse lineup of products designed to treat various eye conditions. Bausch + Lomb is recognized as one of the largest vision care companies in the United States, having recently transitioned to a public company.

Obagi Medical Products is a specialty pharmaceutical company focused on developing and marketing topical aesthetic and therapeutic prescription skin care systems. Founded in 1988 and headquartered in Irvine, California, the company offers a diverse product lineup designed to address various skin concerns, including fine lines, wrinkles, acne, hyperpigmentation, and rosacea. Key offerings include the Obagi Nu-Derm System, Condition and Enhance Systems, Obagi-C Rx System with Vitamin C, and Professional-C serums. Additionally, Obagi provides specialized treatments such as the ELASTIderm Eye and Décolletage, CLENZIderm M.D. Systems, and ReGenica Facial Rejuvenation Complex. Obagi Medical Products distributes its products through a direct sales force and partnerships with dermatologists, plastic surgeons, and other medical professionals both domestically and internationally, ensuring a wide reach in the aesthetic and therapeutic skin care market.

Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada. The company focuses primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the U.S. of products for the treatment of dermatological, aesthetic and podiatric conditions. It also markets products in Canada for the treatment of dermatological and aesthetic conditions The company offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin). The company offers 18 branded products. Its primary brands are PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1%, and ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. The company also sells various other products that it considers less critical to its business. It has various products under development, ranging from new products to existing product line extensions and reformulations of existing products. Products Dermal Restorative Products The company's principal branded dermal restorative products include: RESTYLANE, PERLANE, RESTYLANE FINE LINES and RESTYLANE SUBQ are injectable, transparent, stabilized hyaluronic acid gels, which require no patient sensitivity tests in advance of product administration.

Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.

Probiótica Laboratórios Ltda. is a Brazilian company that specializes in the development, manufacture, and sale of food supplements, primarily focusing on sports nutrition. Founded in 1986 and based in Matão, the company offers a diverse range of products, including amino acids, protein bars, BCAAs, whey protein shakes, creatine capsules, and energy bars. Additionally, it provides various items designed for beauty and health, such as hypercaloric and thermogenic products. Probiótica's offerings are available for purchase online, catering to athletes and health-conscious consumers. In 2018, it became a subsidiary of Supley Laboratório de Alimentos e Suplementos Nutricionais Ltda.

iNova Pharmaceuticals is a manufacturer and marketer of over-the-counter and prescription medicines primarily serving Australia and New Zealand. The company aims to enhance health and well-being by providing a diverse range of pharmaceutical products and services. Its product portfolio encompasses therapeutic areas such as weight management, pain management, cough, cold and flu, dermatology, sun care, respiratory health, and women's health. iNova Pharmaceuticals is committed to delivering effective solutions that cater to the health needs of patients and consumers.

Dermik Laboratories offers therapeutic products to treat acne, actinic keratosis, dermatitis and eczema, insect bites and stings, plant rashes, psoriasis, rosacea, and rough skin; aesthetic products, including HIV facial lipoatrophy products, chemical peels for revitalizing, and skin hydration products; and podiatric products for nail fungus.

PharmaSwiss SA develops and manufactures generics and over-the-counter pharmaceutical products.

Aton Pharma, Inc. is a specialty pharmaceutical company based in Lawrenceville, New Jersey, founded in 2001. The company specializes in treating ophthalmic diseases, orphan conditions, and products for acute care hospitals. Aton Pharma's portfolio includes treatments for metabolic, neurological, and cardiovascular diseases, with a particular emphasis on under-treated conditions such as dry eye. One of its notable products is timolol maleate ophthalmic gel forming solution, designed to manage elevated intraocular pressure in patients suffering from ocular hypertension or open-angle glaucoma. The company serves a diverse array of customers, including patients, caregivers, and healthcare professionals across the United States, the Asia Pacific region, Australia, and other international markets.

Private Formula International is a privately owned medium sized Australian company. It owns and distributes the Dr LeWinns brand through department stores and pharmacies nationally as well as internationally. With 50+ staff based in Australia, the company is a leading innovator of anti-ageing skincare products and treatments providing its consumers with quality products that work at an accessible price point. Private Formula International head office is located at 460 Bay Street, Port Melbourne, Victoria. The company outsources its manufacturing activities through 3 overseas and 4 local suppliers. Private Formula has always been mindful of the potential impact on waste disposals in general and has been concerned on how the global environment changes could impact the future. Private Formula has recently being made aware of a structured organization in this area ie. National Packaging Covenant and fully supports its principles and goals hence, the company is now a signatory of the organization.

Tecnofarma is a Mexican pharmaceutical company that specializes in the production of interchangeable generic medications. It supplies a variety of internal medicines primarily for rheumatology, endocrinology, and cardiology, catering to both government institutions, such as IMSS and ISSSTE, and private label markets. In addition to its generic offerings, Tecnofarma also markets its own line of pharmaceutical products, focusing on meeting the diverse healthcare needs of its clients.

Dow Pharmaceutical Sciences, Inc. engages in the development of topical drug products for pharmaceutical and biotechnology clients.

DermTech, Inc. is a molecular diagnostic company based in La Jolla, California, focused on developing and marketing non-invasive diagnostic tests for skin cancer and related conditions in the United States. The company offers the Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and eliminates the need for surgical biopsies of atypical pigmented lesions. Additionally, DermTech provides the Nevome test, an adjunctive reflex test for the PLA, along with adhesive skin sample collection kits and gene expression assays targeting specific inflammatory pathways. The firm is also working on diagnostic products for non-melanoma skin cancer and risk assessment. DermTech generates revenue primarily by selling its products to pathology and oncology practitioners, and its assays are performed at a CLIA-certified laboratory in San Diego, utilizing adhesive tape biopsy methods to collect skin samples non-invasively.

DermaTech Pty Ltd is an Australian company specializing in the development, production and distribution of innovative products to address common dermatological conditions such as dry, itchy or sensitive skin, acne, eczema, psoriasis, contact dermatitis, insect bites, skin warts and sunburn.

Coria Laboratories, Ltd. is a privately held pharmaceutical company based in Fort Worth, Texas, specializing in research, development and marketing of branded prescription and over-the-counter dermatology products. The company also provides products for dermatomes, atopic dermatitis, seborrheic dermatitis, contact dermatitis, acne, hyperkeratotic skin disorders, ichthyosis, psoriasis, and keratosis pilaris.

Xcel Pharmaceuticals are a specialty pharmaceutical company focused on prescription products that treat disorders of the central nervous system (CNS). They currently focus on neurology, a segment of the CNS market where a limited number of high-prescribing physicians write a significant number of the prescriptions for neurology products. Their product portfolio consists of four commercial products and two product candidates. Their commercial products include two epilepsy products, Diastat® and Mysoline®, and two migraine products, Migranal® and D.H.E. 45®. Their product candidates include MT 300™, a potential treatment for migraine, and retigabine, a potential treatment for epilepsy. their nationwide field sales organization promotes their products to high-prescribing epilepsy and migraine specialists. Their strategy is to increase prescription demand for Their lead products through targeted sales and marketing efforts, to successfully develop and commercialize Their late-stage development product candidates, to leverage Their CNS presence through the acquisition of additional late-stage development product candidates and commercial products, and to develop enhancements for Their current products. Their corporate infrastructure is designed to support Their field sales organization, to manage Their product development efforts, to identify and pursue the acquisition of additional late-stage development product candidates and commercial products, and to manage Their product enhancement efforts. They have developed valuable relationships with experts and third-party consultants that They intend to utilize for the advancement of late-stage development product candidates, including retigabine, through the development and regulatory approval process. They also utilize third parties to manufacture and distribute Their products and to support Their product development and enhancement efforts.